The Stanford Cancer Center provides the most advanced medical
expertise in an environment that focuses on humanity, compassion and
concern. Ongoing collaborations with basic scientists and clinical
researchers in the Stanford
Cancer Institute mean that patients benefit from the latest
discoveries and innovative treatments, leading to better outcomes.
Drawing upon the expertise of more than 300 researchers and
clinicians from the Schools of Medicine, Engineering and Humanities
& Sciences, the Stanford Cancer Institute is at the forefront of
today's advances in cancer research and medicine.
Interdisciplinary research by Stanford experts in cancer biology,
epidemiology and other fields is yielding critical insights into the
origins of cancer, while collaborations between the lab and clinic are
working to move the most promising discoveries into improved
diagnostic, treatment and prevention strategies.
Patients seeking care at Stanford may gain early access to these
emerging therapies-and the benefits that they may offer-through the
center's clinical trials program.
Underlying all of our clinical cancer services is a team of doctors,
nurses, and staff that work together to give you the best care and
most positive experience possible. Our teams collaborate at all stages
of your care, and doctors regularly discuss patient diagnosis and
treatment with other experts on staff.
This video explains how Stanford doctors use the genetics of individual tumors to design a personalized treatment for best results and to guide development of new treatments.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.